Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells
Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells is a paper indexed in PICO Portal from OpenAlex.
How many citations does Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells have?
Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells has 201 citations in the OpenAlex counts PICO Portal stores.
When was Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells published?
Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells has 2007 year in the PICO Portal index.
What is the open-access status of Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells?
Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells has green oa status in the PICO Portal index.
What is the DOI of Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells?
The DOI for Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells is on the source record.
What is the PMID of Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells?
The PMID for Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells is on the source record.
What is the OpenAlex record for Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells?
The OpenAlex for Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4<sup>+</sup>T Cells is on the source record.